Principles of Oxygen Therapy and sleep apnoea Flashcards
Oxygen cylinder
Widely available (home & institutional)
Various sizes
Limited length of supply
Suitable for limited/short duration treatment
Relatively expensive
Supply 100% oxygen
Wall supply
In hospital only
Central supply piped in to clinical areas
Not every ward has this
Supply 100% oxygen
Oxygen Concentrators
Mains operated machine
Molecular sieve- removes nitrogen
Oxygen predominant gas >90% concentration
Use in the home or when out
Regional suppliers with franchise for installation & support
Liquid oxygen
More highly compressed
Larger gaseous volume per cylinder volume
Well developed in US & parts of Europe
Patient interfaces
For spontaneously breathing patients:
Nasal cannulae
Uncontrolled masks (hudson, non-rebreathe)
Controlled (fixed percentage - venturi) masks
Oxygen reaches the patient either as:
litres per minute
percentage inspired oxygen
Nasal cannulae
Usually well tolerated
Accepts flow rates 1-4L/min
Delivers 24-40% O2
(= FiO2 of 0.24-0.4)
% delivered depends on multiple factors
Uses: mild hypoxaemia, not critically ill
Uncontrolled masks - simple face mask
Hudson mask Delivers 30-60% O2 Flow rate 5-10L/min Mixing of O2, room air & exhaled air in mask Used less often
Uncontrolled masks - non rebreathe mask
Delivers 85-90% oxygen with 15L flow rate. Bag: one-way valve stops: mixing with room air patient rebreathing expired air Use: acutely unwell patients Step down as soon as possible.
Venturi mask
Controlled Oxygen
Venturi valve allows delivery of a fixed concentration of oxygen
Clinical indications
Oxygen is a treatment for hypoxaemia, not breathlessness.
Acutely hypoxaemic patients
Chronically hypoxaemic COPD patients with acute exacerbation
Chronically hypoxaemic COPD patients who are stable
Palliative use in advanced malignancy
Sats <90% and breathless, though often multifactorial
Target oxygen saturation - Normal adult average
96-98%
Minimal reduction with age
Target oxygen saturation - Most patients
94-98%
Balance of what is normal and what is safe
Target oxygen saturation - Those at risk of hypercapnic
88-92%
May be lower for some
Remember not just about oxygen
Secure and maintain airway patency
Enhance circulation
(volume, anaemia, cardiac output)
Avoid/reverse respiratory depressants
Establish reason for hypoxaemia and treat
e.g. bronchospasm (in asthma), pulmonary oedema (in left ventricular failure).
If not improving, may need ventilation
Invasive or non-invasive
Hypercapnia (CO2 retention) risk with high oxygen dose
Chronic hypoxic lung disease - COPD - Bronchiectasis / Cystic fibrosis Chest wall disease - Kyphoscoliosis - Thoracoplasty Neuromuscular disease Obesity hypoventilation
Aims of treatment
To maintain modest oxygenation whilst preventing CO2 retention & acidosis
Deliver oxygen by fixed percentage venturi oxygen masks starting at 24% (controlled oxygen therapy)
Target saturations 88-92%
Assess response to treatment
arterial blood gases, check frequently - pO2 <10 - pCO2 falling from peak or maintained <6.0 - pH increasing/maintained >7.35 Adjust dose of oxygen accordingly
If not improving may need non-invasive ventilation
Don’t always use nasal cannulae
- potentially dangerous as actual inspired oxygen percentage varies according to the patient’s respiratory characteristics
- Uncontrolled therapy
Prescribing Oxygen - British Thoracic Society Guidelines
State:
the target oxygen saturation range
Depends on the clinical scenario
the delivery device
Controlled vs uncontrolled (venturi or nasal cannulae)
the “dose” – flow rate or percentage of inspired oxygen
You may provide a range here to guide ward staff
But may be more important to work to saturation targets
Patients may carry an ‘oxygen treatment card’ with their recommended oxygen saturations/prescription.
When to suggest long term oxygen treatment
For some patients with COPD
Specialist assessment:
- In patient’s stable state
- ABGs on 2 occasions at least 3 weeks apart to demonstrate clinical stability
- no sooner than 4 weeks after an exacerbation
Long term oxygen treatment indications
COPD patients with pO2 < 7.3 kPa or COPD patients with pO2 7.3 < 8 kPa AND: secondary polycythaemia nocturnal hypoxaemia peripheral oedema evidence of pulmonary hypertension
Long term oxygen treatment
Provided from an oxygen concentrator
Regional concentrator supply service
O2 treatment for ≥15 hours per day
Benefits of long term oxygen treatment
Improved long term survival Prevention of deterioration in pulmonary hypertension Reduction of polycythaemia (raised Hb) Improved sleep quality Increased renal blood flow Reduction in cardiac arryhthmias Improved quality of life
Portable oxygen
May improve breathlessness in some patients
May extend duration of LTOT
But ….
Most patients breathlessness is not due to low pO2
Weight of cylinders
Duration of supply
Apneoa
“Cessation of Airflow” for 10 seconds or longer
Obstructiuve
collapse of pharyngeal airway during sleep (continuation of respiratory effort)
OSA
5 or more obstructive apnoeas per hour.
Hypopneoa
reduction in airflow by 50% accompanied by desaturation of 4% and/or arousal from sleep
Apneoa risk factors
Male sex
Obesity
Neck circumference greater than 43 cm (41cm women)
Family history of OSAS
Smoking
Alcohol/sedative use
Craniofacial abnormalities (e.g retrognathia)
Pharyngeal abnormalities (e.g. tonsillar enlargement)
Some medical conditions (hypothryroidism, acromegaly, pregnancy)
Sleeping supine
Clinical features of apnoea
Snoring (Hx often from partner) Nocturnal choking/waking with a “start” Unrefreshing/restless sleep Morning dry mouth Morning headaches Excessive daytime sleepiness
Nocturia
Apnoea investigation
Epworth Sleepiness Scale Sleep Studies Nocturnal oximetry Video studies Polysomnography
Consequences of OSA
Increased risk of accidents Association with: - Hypertension - Type 2 diabetes - Ischaemic heart disease - Heart failure - Cerebrovascular disease/stroke - Cardiac arrhythmias - Death
Management
Goals Resolve signs and symptoms of OSA Improve sleep quality Normalise: apnoea-hypopnoea index (AHI) oxyhaemoglobin saturation levels
Multi-disciplinary approach needed
Mandibular advancement devices
Hold soft tissues of oropharynx forward
Mild-mod OSA, patient preference, failed CPAP
Continuous Positive Airway Pressure (CPAP)
Device generates airflow => positive pressure delivered to airway via mask
Intraluminal pharyngeal pressure > surrounding pressure
Pharynx stays open
CPAP benefits
Benefits Symptoms resolve ↓ apnoea/hypopnoea ↓ daytime sleepiness ↓ risk road accidents ↑ quality of life Normalises BP
CPAP problems
Adherence an issue Airway drying/irritation Can humidify Mask problems Air leak Comfort Life long treatment